OmniComm's TrialMaster Added to Kendle's Suite of eClinical Solutions in Multi-Year Agreement
Fort Lauderdale, FL-September 30, 2009
In a multi-year enterprise-wide agreement Kendle will add OmniComm’s TrialMaster EDC solution to its current eClinical offerings.
“Efficient delivery of high-quality data is critical to Kendle’s continued success as a leading provider of clinical data management services,” said John Fontenault, Executive Director and Global Head, Clinical Data Management and Technology. "The addition of the TrialMaster EDC solution to our existing offerings supports Kendle’s focus on providing our global biopharmaceutical customers with cost-effective access to the best eClinical solutions to accelerate their Phase I through IV clinical trials. The TrialMaster platform offers the right mix of functionality to streamline the study development process and drive efficient study operations.”
"We are excited to be working with Kendle to meet the needs of its diverse customer base," said Stephen Johnson, COO of OmniComm Systems. "Kendle is one of the largest and most respected and successful top-tier global CROs with extensive eClinical experience, having conducted more than 250 trials utilizing EDC technologies to expedite the clinical trials process. We look forward to providing them the eClinical solutions and services needed to support their continued delivery of best-in-class clinical development services to their customers.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
